Trial
NCT06005662
Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Opioid Use Disorder
Intervention
Psilocybin
Why stopped
This study was de-prioritized in favor of the similar BIPOD-Out protocol due to a combination of practical considerations and expense. There are currently no plans to initiate this protocol.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-23